Bumetanide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bumetanide Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on 01/31/2018.
Shortage Details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-321-10
- Dosage Form
- Injection
- Presentation
- Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10)
- Initial Posting
- 01/31/2018
- Revised Date